4//SEC Filing
Loeillot Olivier 4
Accession 0000950170-25-031547
CIK 0000730272other
Filed
Mar 3, 7:00 PM ET
Accepted
Mar 4, 1:18 PM ET
Size
7.3 KB
Accession
0000950170-25-031547
Insider Transaction Report
Form 4
REPLIGEN CORPRGEN
Loeillot Olivier
DirectorChief Executive Officer
Transactions
- Award
Common Stock
2025-03-03+14,480→ 46,693 total - Award
Stock Option (Right to Buy)
2025-03-03+13,627→ 13,627 totalExercise: $155.38Exp: 2035-03-03→ Common Stock (13,627 underlying)
Footnotes (2)
- [F1]Mr. Loeillot was awarded 14,480 restricted stock units. Each restricted stock unit represents a contingent right to receive one share of Repligen Corporation's Common Stock. The restricted stock units vest in equal annual instalments over a three-year period beginning on the first anniversary of the grant date. The restricted stock units may be settled only by delivering shares of Repligen Corporation's Common Stock, and thus, the grant is being reported in Table 1 as allowed per SEC guidance.
- [F2]One third of the stock options will vest and become exercisable annually on March 3, 2026, March 3, 2027, and March 3, 2028.
Documents
Issuer
REPLIGEN CORP
CIK 0000730272
Entity typeother
Related Parties
1- filerCIK 0001995525
Filing Metadata
- Form type
- 4
- Filed
- Mar 3, 7:00 PM ET
- Accepted
- Mar 4, 1:18 PM ET
- Size
- 7.3 KB